Results showed that topic-specific classifiers reduced subgroup disparity compared to the topic-general classifier, and a factorization approach to decompose complex data into simpler components by reducing topic dimensions of clinical transcripts was proposed.
Abstract
While artificial intelligence (AI) and large language models (LLMs) have shown promise in identifying and classifying suicidal ideation, their generalizability and equity in the presence of heterogeneous clinical data remain largely unexplored. This study hypothesized a subgroup disparity in a crude AI classifier of clinician-rated suicidal ideation because of the linguistic heterogeneity and proposed a factorization approach to decompose complex data into simpler components by reducing topic dimensions of clinical transcripts. Results showed that topic-specific classifiers reduced subgroup disparity compared to the topic-general classifier, with ΔAUC decreasing from 0.11 to 0.01 and 0.05—a noticeable reduction of 0.10 and 0.06, respectively. More specifically, with the topic-general classifier, the odds of missing a suicidal case increased by 2.39 times for alexithymia individuals, compared to non-alexithymia individuals (OR = 2.39,
p
= 0.002). These findings underscore the significance of data heterogeneity on AI classifiers of suicidal ideation and demonstrate the potential of the proposed factorization approach.
A novel and effective oversampling method that leverages a predictive model to generate nominal variables, rather than interpolating them and is significantly better than existing oversampling approaches in predicting elevated symptoms of amotivation and anhedonia.
Dang Nguyen, Bao Duong, Arun Kumar et al.· 0 citations
BACKGROUND
The wide-ranging correlates (e.g., demographic, socioeconomic status [SES], brain, genetics) of alcohol use disorder (AUD) are typically characterized by small effects and studied in isolation. Novel multivariable nonlinear approaches may help characterize the multifaceted correlates of AUD and identify its...
A. Hatoum, Alex P. Miller, H. Mathews et al.· Alcohol, clinical & experime...· 0 citations
A decorrelated, clinician-aligned symptom signal readable directly from internal activations is revealed, offering a mechanistic foundation for interpretable depression-assessment tools.
Fang-Ying Zhu, Ajay K. Subramanian, A. Constant et al.· 1 citation
This approach advances efforts toward precision neuropsychopharmacology by identifying reproducible brain–behavior relationships that may inform treatment selection and mechanistic targeting and provides a scalable framework for biologically informed subtyping in MDD.
K. Dunlop· International Journal of Neu...· 0 citations
Suicidal ideation (SI) and major depressive disorder (MDD) are complex psychiatric conditions arising from the interplay of genetic liability, molecular processes, and psychosocial factors. While these dimensions have been extensively studied in isolation, their joint contribution to SI and MDD remains unclear. This st...
The widespread use of LLMs among psychiatric populations has raised concerns regarding their safety and potential iatrogenic impact in the context of AI psychosis. While growing literature conceptualizes AI psychosis and documents case studies, empirical evidence tracing AI-exacerbated psychotic processes remains scarc...
Anna Sterna, Kacper Dudzic, K. Drożdż et al.· 0 citations
Research Manager Mike Walker reflects on a career spanning hacker culture, cybersecurity, and AI, sharing lessons about trust, teamwork, leadership, and why solving difficult problems requires curiosity, judgment, agility—and an understanding of the rules. The post Learn the rules: The hacker mindset appeared first on Microsoft Research.
Is your company’s AI sovereign? A practical guide for CIOs on AI vendor lock-in, EU Data Act switching, cloud sovereignty, and testing your exit plan before you need it. The post Sovereignty Is the Option to Leave appeared first on GPT-Lab.
MIT News · Artificial Intelligence· news.mit.eduNov 2, 2026
The MIT professors collaborated to identify the first AI-discovered antibiotic, a scientific breakthrough that is widely recognized as a milestone in AI-driven drug discovery.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.